| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| Gene symbol | CD22 | Synonyms | SIGLEC-2, SIGLEC2 | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.12 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | CD22 molecule | ||||
| GTO ID | GTC1945 |
| Trial ID | NCT03620058 |
| Disease | Acute Lymphoblastic Leukemia |
| Altered gene | CD19|CD22 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CAR-T22-65s|CD19 CAR-T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | CART22 Alone or in Combination With huCART19 for ALL |
| Year | 2018 |
| Country | United States |
| Company sponsor | University of Pennsylvania |
| Other ID(s) | IRB # 830049; UPCC #12418 |
| Vector information | |||||
|
|||||
| Cohort1: CD22 | |||||||||
|
|||||||||
| Cohort2: CD22+CD19 | |||||||||
|
|||||||||